Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2069163 Target Snapshot

Dual specificity testis-specific protein kinase 2 · SINGLE PROTEIN · Homo sapiens

174Compounds
13Assays
0Approved Drugs
168.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q96S53. Use UniProt Q96S53 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q96S53 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dual specificity testis-specific protein kinase 2 as ChEMBL target CHEMBL2069163, mapped to UniProt Q96S53. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dual specificity testis-specific protein kinase 2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2069163
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q96S53
Dual specificity testis-specific protein kinase 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dual specificity testis-specific protein kinase 2 is the right protein anchor across sources, using UniProt Q96S53 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDual specificity testis-specific protein kinase 2
UniProt AccessionQ96S53
Component TypeProtein
Sequence Length571 aa

Dual specificity testis-specific protein kinase 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dual specificity testis-specific protein kinase 2, mapped to UniProt Q96S53. Sequence length is 571 aa.

Mapped IDQ96S53
Review nameDual specificity testis-specific protein kinase 2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC5026.0
KD142.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3752910 9.11 Kd 0.772 Preclinical
CHEMBL1738757 8.7 Kd 2.0 Clinical
CHEMBL5653589 8.46 Kd 3.488 Preclinical
CHEMBL3991933 7.75 Kd 18.0 Preclinical
CHEMBL2070615 6.6 IC50 252.0 Preclinical
CHEMBL2070613 6.38 IC50 415.0 Preclinical
CHEMBL2070614 6.38 IC50 415.0 Preclinical
CHEMBL2070616 6.21 IC50 612.0 Preclinical
CHEMBL4088216 6.0 IC50 1000.0 Preclinical
CHEMBL4097778 6.0 IC50 1000.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
2
5.5
6
6.0
1
6.5
0
7.0
1
7.5
1
8.0
1
8.5
1
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

13
Total Assays
13
Tested Compounds
1
Assay Types
Binding — 13 assays, 13 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 12 11 6.6
subcellular format 1 2 8.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine